RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease
de Wit J., Al-Mossawi MH., Hühn MH., Arancibia-Cárcamo CV., Doig K., Kendrick B., Gundle R., Taylor P., Mcclanahan T., Murphy E., Zhang H., Barr K., Miller JR., Hu X., Aicher TD., Morgan RW., Glick GD., Zaller D., Correll C., Powrie F., Bowness P.